Search Results 3411-3420 of 25027 for oral

  1. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial (FASTEST) - Mayo Clinic

    Secondary ICH related to known causes (e.g., trauma, aneurysm, arteriovenous malformation (AVM), oral anticoagulant use (vitamin K antagonists or novel oral ...

  2. Publications - Charles L. Loprinzi, M.D. - Mayo Clinic

    Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2020 ...

  3. Publications - Malini Madhavan, M.B.B.S. - Mayo Clinic

    Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J. 2019 May; 211:77-89 ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  5. Razvan M. Chirila, M.D. - Doctors and Medical Staff - Mayo Clinic

    Annual ACP Meeting- Michigan Chapter-Winner 3rd prize oral presentationsMichigan Chapter, American College of Physicians. 2002. Walter J. Zimmerman, M.D. ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  9. Dermatitis Clinical Trials - Mayo Clinic Research

    The purpose of this study is to compare the assessment of the composition of the fecal, nasal,oral and skin microbiota in patients with AD (cases) as ...

  10. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

    Subjects who have initiated or had a dose change of any of the following within 2 weeks of screening: oral, topical, or IV vasodilators (e.g., calcium ...